Volume 19, Number 9—September 2013
Mumps Postexposure Prophylaxis with a Third Dose of Measles-Mumps-Rubella Vaccine, Orange County, New York, USA
Medscape, LLC is pleased to provide online continuing medical education (CME) for this journal article, allowing clinicians the opportunity to earn CME credit.
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of Medscape, LLC and Emerging Infectious Diseases. Medscape, LLC is accredited by the ACCME to provide continuing medical education for physicians.
Medscape, LLC designates this Journal-based CME activity for a maximum of 1 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
All other clinicians completing this activity will be issued a certificate of participation. To participate in this journal CME activity: (1) review the learning objectives and author disclosures; (2) study the education content; (3) take the post-test with a 70% minimum passing score and complete the evaluation at www.medscape.org/journal/eid; (4) view/print certificate.
Release date: AUGUST 22, 2013; Expiration date: AUGUST 22, 2014
Upon completion of this activity, participants will be able to:
• Assess means to prevent mumps
• Distinguish recommendations regarding the use of the measles-mumps-rubella (MMR) vaccine as postexposure prophylaxis
• Analyze the presentation of mumps among patients in the current study
• Assess the effectiveness of the MMR vaccine as postexposure prophylaxis during an outbreak of mumps.
Carol E. Snarey, MA, Technical Writer/Editor, Emerging Infectious Diseases. Disclosure: Carol E. Snarey, MA, has disclosed no relevant financial relationships.
Charles P. Vega, MD, Health Sciences Clinical Professor; Residency Director, Department of Family Medicine, University of California, Irvine. Disclosure: Charles P. Vega, MD, has disclosed no relevant financial relationships.
Disclosures: Amy Parker Fiebelkorn, MSN, MPH; Jacqueline Lawler, MPH, CPH; Aaron T. Curns, MPH; Christina Brandeburg, BS; and Gregory S. Wallace, MD, MS, MPH, have disclosed no relevant financial relationships.
Comments to the EID Editors
Please contact the EID Editors via our Contact Form.
- Page created: August 23, 2013
- Page last updated: August 23, 2013
- Page last reviewed: August 23, 2013
- Centers for Disease Control and Prevention,
National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)
Office of the Director (OD)